Javier Cubero retweeted
🤝 Gracias, @AEEHLiver, por invitarnos a la 8ª Reunión de Hepatología Traslacional en #Salamanca.
La semana pasada participamos en la mesa redonda de un encuentro que reunió a casi un centenar de especialistas con un objetivo muy claro: acercar la investigación básica y traslacional a la práctica clínica. Es justo ahí donde se decide buena parte del futuro de los pacientes con tumores de vías biliares.
Que la voz de los pacientes tenga un sitio en una reunión científica como esta no es algo menor. Nos llevamos conversaciones, contactos y muchas ganas de seguir colaborando. 💚
#AEEH #Colangiocarcinoma #PacientesOncológicos #TumoresDeVíasBiliares #Confía
La tercera edición del Máster en Investigación Traslacional en Enfermedad Hepática e Intestinal comenzará el 5 de octubre de 2026. Conoce esta propuesta académica en mith-formacion.es/
100 % en línea, impartida en español y con acompañamiento de tutores personales.
#AMH
🤖 Made with AI
Javier Cubero retweeted
In this paper, we hv also discussed how cardioprotective polyunsaturated fatty acids (PUFAs) in healthy individuals become hepatotoxic in the setting of MASLD.
gut.bmj.com/content/early/20…
Javier Cubero retweeted
Excited to share our latest paper in @Gut_BMJ Fruits of 6-month hard work. With amazing guys @Brunorm84 @CUBEROlab
A paper in recent advances in MASH basic sciences 🙏🏼
gut.bmj.com/content/early/20…
Javier Cubero retweeted
Happy to share our new publication, out now in @Gut_BMJ (IF=24.6)!! “#Ferroptosis, immune activation and #MASH-related #HCC”. Proud to have worked with @drshafikuchay and @CUBEROlab on this review. @IMIB_RMurcia @FFIS_CARM gut.bmj.com/content/early/20…
Javier Cubero retweeted
🔜 Next #InternationalSeminarSeriesonLiverToxicityandSteatoticLiverDisease
🗓️ 20 May · 16:30h (CEST)
💻 Gerd Kullak‑Ublick (University Hospital Zurich🇨🇭)
A leading expert in Drug‑Induced Liver Injury will explore cutting‑edge biomarkers emerging from the TransBioLine Consortium.
A must‑attend session for researchers, clinicians and anyone following the future of liver safety science.
♾ Sign in: bit.ly/42Cab3E
#LiverToxicity #DILI #Biomarkers #SteatoticLiverDisease #Hepatology #TransBioLine #ClinicalPharmacology
📢 #ArtículoMes @chantarlab @mariamergom @CUBEROlab @CICbioGUNE
Investigadores exploran el papel de CNNM4 en la progresión del colangiocarcinoma, con implicaciones para la ferroptosis y nuevas terapias.
🌟Lee más: f.mtr.cool/jatfxmjbxb
Javier Cubero retweeted
🔜 25𝐭𝐡 𝐇𝐞𝐩𝐚𝐭𝐨𝐥𝐨𝐠𝐲 𝐌𝐞𝐞𝐭𝐢𝐧𝐠 2026
🔝 International experts
✅ Special DILI session (25th anniversary)
💊 Updates in hepatitis, MASLD & cirrhosis
🔗 Registration: bit.ly/48eTSge
📌 Programme: bit.ly/3OjA4Sa
ℹ️ jornadasavancehepatologia.um…
Javier Cubero retweeted
🚨 NEW VENUE THE GREEN RAY (Auditorium)
🌍 Experts from the USA, UK, France, Italy, Iceland and Spain gather in Málaga for the 25th Hepatology Meeting 2026
🔗bit.ly/48eTSge
ℹ️jornadasavancehepatologia.um…
@CIBER_ISCIII
🔜 25𝐭𝐡 𝐇𝐞𝐩𝐚𝐭𝐨𝐥𝐨𝐠𝐲 𝐌𝐞𝐞𝐭𝐢𝐧𝐠 2026
🔝 International experts
✅ Special DILI session (25th anniversary)
💊 Updates in hepatitis, MASLD & cirrhosis
🔗 Registration: bit.ly/48eTSge
📌 Programme: bit.ly/3OjA4Sa
ℹ️ jornadasavancehepatologia.um…
Javier Cubero retweeted
Alcohol in combination with a Western Diet synergistically exacerbated steatotic liver disease in mice. Nice work by @NevzorovaYulia @BenedeRaquel in which we could collaborate. tandfonline.com/doi/full/10.…
Javier Cubero retweeted
Published at last! 🥳 @BenedeRaquel 🥳. Huge shoutout to all our wonderful cooperation partners 👏 @CUBEROlab @AreaUcm @FMedicinaUniCM @unicomplutense @HaltRONIN22 #metald #gutliveraxis tandfonline.com/doi/full/10.…
Javier Cubero retweeted
We are back!! I'm excited to share our new paper from @RubenNogueiras lab at @cimususc , where we identified the key role of PCK1 in liver fibrosis progression. Key findings below...👇
New! Online now: Lack of PCK1 in hepatic stellate cells causes liver fibrosis by fueling tricarboxylic acid cycle and increasing glycolysis dlvr.it/TR6mSR
Javier Cubero retweeted
Un hilo muy claro de la discriminación que realiza el gobierno creando nuevas castas de investigadores en nuestro país para ponerse medallas: los que llevan toda la vida dando lo todo por su país en un Dacia, los que vienen de fuera en un Mercedes
Con nocturnidad y alevosía 👇
1/Hoy @el_pais publica que se duplican las solicitudes de científicos de EE.UU. para venirse a España. Vamos a comparar el programa ATRAE con las condiciones del PDI que ya está dentro 🧵
elpais.com/ciencia/2026-02-2…
Javier Cubero retweeted
We also say goodbye and thank you, as well as warmly welcome, a number of members of #TeamGUT
We say a huge thank you to Professor Alexander Gerbes @AlexanderGerbes, Professor Guy Boeckxstaens @BoeckxstaensLab, Professor Patrice Cani, Professor Jean-Francois Dufour @dufour_jf, Professor Christian Jobin, Professor Herbert Tilg, Professor Akbar Waljee @AkbarWaljee, and Professor Fabien Zoulim. Thank you for everything you have done for @Gut_BMJ from Professor Emad El-Omar @emadelomar and all at #TeamGUT
We warmly welcome some new research superstars to the #TeamGUT fold from around the globe. We welcome Professor Hongliang Li, Professor Alexander Ford @alex_ford12399, Professor Debbie Shawcross @DebbieShawcros, Professor Nageshwar Reddy @DrDNReddy, Professor Amit Singal @docamitgs, Professor Jonel Trebicka @JonelTrebicka, Professor Chiara Braconi @chiarabraconi, Professor Nadim Mahmud @nadimmahmud and Professor Francisco Javier Cubero @CUBEROlab. It is great to have you as part of #TeamGUT
We look forward to the new and exciting developments ahead in 2026 and beyond
#GUTPortfolio @FrontGastro_BMJ @BMJOpenGastro @BritScoGastro #GUTScience @bmj_company
Javier Cubero retweeted
🚀 Announcing the 1st Edition of the Advanced Course in Advanced Models for Predictive Toxicology!
📍 FFUL @facfarmaciaUL
🗓️ November 25–27 + December 19, 2025(assessment)
🔬 This course brings together leading international and national experts in in silico, in vitro, and in vivo models, exploring their role from drug discovery to translational research.
✨ Highlights:
✅Advanced in vitro systems in safety assessment
✅Emerging in vivo models
✅Bioinformatic tools & personalised predictive toxicology
🎯 A unique opportunity to:
🔹Learn directly from top experts
🔸Bridge basic science with clinical applications
🔹Discover cutting-edge solutions in predictive toxicology, integrating non-clinical data
👉 Don’t miss this transformative experience at FFUL!
Javier Cubero retweeted
👀👀Nueva convocatoria Contratos Ramón y Cajal aei.gob.es/convocatorias/bus… También en la @unicomplutense @FMedicinaUniCM @FarmaMed_UCM Tres de nuestros seniors en @neurofarmaucm fueron RyC
Javier Cubero retweeted
Exciting meetings in Shanghai and Nanjing on the occasion of the newly funded NSFC between the Tongji University, the Nanjing Medical School and the @unicomplutense @AreaUcm 2025-2030
Javier Cubero retweeted
Members of the @CUBEROlab at @unicomplutense presented their results at the International Conference on TGFbeta family signaling in health and disease huiyi.cn-healthcare.com/web/… at Ningbo (China) @easldhili @EU_HaDEA @Sigue_MICINN @exohep @ComunidadMadrid
Javier Cubero retweeted
Congrats Maider!!
📣Congrats to Maider Apodaka-Biguri for her PhD defense!!! A beautiful day surrounded by a wonderful PhD Committee and all lab members and family and not to forget the interesting discussion! @BGosan #patrickrensen @CUBEROlab
Exciting meetings in Shanghai and Nanjing on the occasion of the newly funded NSFC between the Tongji University, the Nanjing Medical School and the @unicomplutense @AreaUcm 2025-2030












































